App is temporarily unavailable
Description
App是一款用于支架患者的用户，给用户提供线上咨询医生，进行分析病情的应用，方便患者，快捷方便的咨询。
Screenshots
支架随访通 FAQ
-
Is 支架随访通 free?
Yes, 支架随访通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 支架随访通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 支架随访通 cost?
支架随访通 is free.
-
What is 支架随访通 revenue?
To get estimated revenue of 支架随访通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in China yet.
Ratings History
支架随访通 Reviews
App doesn't have any reviews yet
支架随访通 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
移动随访
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
随访易-专注患者临床试验管理
ePRO for Patient
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
小乐云医
云医生
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
一院慢病通
慢病管理医生端
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
健康随访
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
心脏瓣膜疾病临床数据平台
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
云随访
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
海贝随访
患者随访复查提醒记录
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
患者随访系统
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
图形病历本
病例整理秒变图表
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
支架随访通 Installs
Last 30 days
支架随访通 Revenue
Last 30 days支架随访通 Revenue and Downloads
Gain valuable insights into 支架随访通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 新疆优若通网络科技有限公司
- Languages
- Recent release
- 1.0.3 (3 years ago )
- Released on
- Apr 6, 2021 (3 years ago )
- Also available in
- China , United States
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.